Shenzhen New Industries Biomedical Engineering Co., Ltd.

SZSE:300832 Stock Report

Market Cap: CN¥55.2b

Shenzhen New Industries Biomedical Engineering Balance Sheet Health

Financial Health criteria checks 6/6

Shenzhen New Industries Biomedical Engineering has a total shareholder equity of CN¥8.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥8.8B and CN¥717.1M respectively. Shenzhen New Industries Biomedical Engineering's EBIT is CN¥2.0B making its interest coverage ratio -19.3. It has cash and short-term investments of CN¥2.6B.

Key information

0%

Debt to equity ratio

CN¥0

Debt

Interest coverage ratio-19.3x
CashCN¥2.59b
EquityCN¥8.12b
Total liabilitiesCN¥717.12m
Total assetsCN¥8.84b

Recent financial health updates

No updates

Recent updates

Investors Don't See Light At End Of Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Tunnel

Dec 15
Investors Don't See Light At End Of Shenzhen New Industries Biomedical Engineering Co., Ltd.'s (SZSE:300832) Tunnel

Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)

Nov 17
Investors Shouldn't Overlook The Favourable Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832)

Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?

Oct 14
Should You Be Adding Shenzhen New Industries Biomedical Engineering (SZSE:300832) To Your Watchlist Today?

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Aug 25
Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Jul 01
A Look At The Intrinsic Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

Apr 09
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today

The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Mar 18
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence

Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Mar 01
Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)

Financial Position Analysis

Short Term Liabilities: 300832's short term assets (CN¥4.7B) exceed its short term liabilities (CN¥598.6M).

Long Term Liabilities: 300832's short term assets (CN¥4.7B) exceed its long term liabilities (CN¥118.5M).

Debt to Equity History and Analysis

Debt Level: 300832 is debt free.

Reducing Debt: 300832 had no debt 5 years ago.

Debt Coverage: 300832 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 300832 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 09:43
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen New Industries Biomedical Engineering Co., Ltd. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Jin ZhangChina International Capital Corporation Limited
Zhu ChenCitic Securities Co., Ltd.